Clinical Trials Directory

Trials / Completed

CompletedNCT00536068

Platelet Inhibition by Aspirin, Acetaminophen and NSAID

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Kantonsspital Graubünden · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Nonsteroidal antiinflammatory drugs such as diclofenac or naproxen may interfere with the inhibition of platelet aggregation by aspirin, because they all interact with the platelet cyclooxygenase.This may be of great clinical importance because of an increased cardiovascular event rate (myocardial infarction, stroke). The present randomized, controlled study analyses in vitro platelet aggregation under a combined treatment of healthy volunteers with aspirin and either acetaminophen, diclofenac, naproxen, or placebo.

Detailed description

An in vivo study on healthy volunteers with combinations of well established drugs

Conditions

Interventions

TypeNameDescription
DRUGAcetylsalicylic acid, acetaminophen, diclofenac, naproxen, placebo1. Acetylsalicylic acid 100mg/po and acetaminophen 3x1g/po for 4 days 2. Acetylsalicylic acid 100mg/po and diclofenac 3x50mg/po for 4 days 3. Acetylsalicylic acid 100mg/po and naproxen 3x250mg/po for 4 days 4. Acetylsalicylic acid 100mg/po and placebo 3x1/po for 4 days

Timeline

Start date
2006-08-01
Completion
2007-08-01
First posted
2007-09-27
Last updated
2007-09-28

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT00536068. Inclusion in this directory is not an endorsement.

Platelet Inhibition by Aspirin, Acetaminophen and NSAID (NCT00536068) · Clinical Trials Directory